ArticleThe Journal of clinical investigation2010

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts.

Christophe Ginestier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.